BML Pharmaceuticals Overview
- Year Founded
-
1996

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
BML Pharmaceuticals General Information
Description
Developer of proprietary prescriptive pharmaceutical products in the areas of cancer treatment. The company's products are formulated into therapeutics which range from the prevention and treatment of dermal disease to mucositis for cancer patients.
Contact Information
Website
www.bmlpharm.comCorporate Office
- 1129 Northern Boulevard
- Suite 406
- Manhasset, NY 11030
- United States
Corporate Office
- 1129 Northern Boulevard
- Suite 406
- Manhasset, NY 11030
- United States
BML Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
BML Pharmaceuticals Patents
BML Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2002332927-A8 | Method of preventing mucositis | Inactive | 06-Sep-2001 | ||
AU-2002332927-A1 | Method of preventing mucositis | Inactive | 06-Sep-2001 | ||
US-20030059378-A1 | By applying to oral, pharyngeal, esophogeal, gastrointestinal and other mucosal tissues triclosan alone or in combination with a cationic agent such as chlorhexidine or benzalkonium chloride; for immunocompromised patients | Inactive | 06-Sep-2001 | ||
US-6537526-B2 | Triclosan in combination with a non-toxic polyhydric alcohol and a poloxamer. | Inactive | 08-May-2001 | ||
US-20020187107-A1 | Triclosan in combination with a non-toxic polyhydric alcohol and a poloxamer. | Active | 08-May-2001 | A61K8/90 |
BML Pharmaceuticals Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
BML Pharmaceuticals FAQs
-
When was BML Pharmaceuticals founded?
BML Pharmaceuticals was founded in 1996.
-
Where is BML Pharmaceuticals headquartered?
BML Pharmaceuticals is headquartered in Manhasset, NY.
-
What industry is BML Pharmaceuticals in?
BML Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is BML Pharmaceuticals a private or public company?
BML Pharmaceuticals is a Private company.
-
What is the current valuation of BML Pharmaceuticals?
The current valuation of BML Pharmaceuticals is
. -
What is BML Pharmaceuticals’s current revenue?
The current revenue for BML Pharmaceuticals is
. -
Who are BML Pharmaceuticals’s investors?
Antares Capital (Florida) has invested in BML Pharmaceuticals.
-
When was BML Pharmaceuticals acquired?
BML Pharmaceuticals was acquired on 29-Jul-2002.
-
Who acquired BML Pharmaceuticals?
BML Pharmaceuticals was acquired by Endo International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »